RATIONALE: Increased food consumption following ∆(9)-tetrahydrocannabinol-induced cannabinoid type 1 receptor agonism is well documented. However, possible non-∆(9)-tetrahydrocannabinol phytocannabinoid-induced feeding effects have yet to be fully investigated. Therefore, we have assessed the effects of the individual phytocannabinoids, cannabigerol, cannabidiol and cannabinol, upon feeding behaviors. METHODS: Adult male rats were treated (p.o.) with cannabigerol, cannabidiol, cannabinol or cannabinol plus the CB(1)R antagonist, SR141716A. Prior to treatment, rats were satiated and food intake recorded following drug administration. Data were analyzed for hourly intake and meal microstructure. RESULTS: Cannabinol induced a CB(1)R-mediated increase in appetitive behaviors via significant reductions in the latency to feed and increases in consummatory behaviors via increases in meal 1 size and duration. Cannabinol also significantly increased the intake during hour 1 and total chow consumed during the test. Conversely, cannabidiol significantly reduced total chow consumption over the test period. Cannabigerol administration induced no changes to feeding behavior. CONCLUSION: This is the first time cannabinol has been shown to increase feeding. Therefore, cannabinol could, in the future, provide an alternative to the currently used and psychotropic ∆(9)-tetrahydrocannabinol-based medicines since cannabinol is currently considered to be non-psychotropic. Furthermore, cannabidiol reduced food intake in line with some existing reports, supporting the need for further mechanistic and behavioral work examining possible anti-obesity effects of cannabidiol.
RATIONALE: Increased food consumption following ∆(9)-tetrahydrocannabinol-induced cannabinoid type 1 receptor agonism is well documented. However, possible non-∆(9)-tetrahydrocannabinolphytocannabinoid-induced feeding effects have yet to be fully investigated. Therefore, we have assessed the effects of the individual phytocannabinoids, cannabigerol, cannabidiol and cannabinol, upon feeding behaviors. METHODS: Adult male rats were treated (p.o.) with cannabigerol, cannabidiol, cannabinol or cannabinol plus the CB(1)R antagonist, SR141716A. Prior to treatment, rats were satiated and food intake recorded following drug administration. Data were analyzed for hourly intake and meal microstructure. RESULTS:Cannabinol induced a CB(1)R-mediated increase in appetitive behaviors via significant reductions in the latency to feed and increases in consummatory behaviors via increases in meal 1 size and duration. Cannabinol also significantly increased the intake during hour 1 and total chow consumed during the test. Conversely, cannabidiol significantly reduced total chow consumption over the test period. Cannabigerol administration induced no changes to feeding behavior. CONCLUSION: This is the first time cannabinol has been shown to increase feeding. Therefore, cannabinol could, in the future, provide an alternative to the currently used and psychotropic ∆(9)-tetrahydrocannabinol-based medicines since cannabinol is currently considered to be non-psychotropic. Furthermore, cannabidiol reduced food intake in line with some existing reports, supporting the need for further mechanistic and behavioral work examining possible anti-obesity effects of cannabidiol.
Authors: América A Scopinho; Francisco S Guimarães; Fernando M A Corrêa; Leonardo B M Resstel Journal: Pharmacol Biochem Behav Date: 2011-01-14 Impact factor: 3.533
Authors: C C Felder; K E Joyce; E M Briley; J Mansouri; K Mackie; O Blond; Y Lai; A L Ma; R L Mitchell Journal: Mol Pharmacol Date: 1995-09 Impact factor: 4.436
Authors: Gareth Pryce; Zubair Ahmed; Deborah J R Hankey; Samuel J Jackson; J Ludovic Croxford; Jennifer M Pocock; Catherine Ledent; Axel Petzold; Alan J Thompson; Gavin Giovannoni; M Louise Cuzner; David Baker Journal: Brain Date: 2003-07-22 Impact factor: 13.501
Authors: Daniel I Brierley; James Samuels; Marnie Duncan; Benjamin J Whalley; Claire M Williams Journal: Psychopharmacology (Berl) Date: 2015-10-06 Impact factor: 4.530
Authors: Anna Paula Marçal; Nícia Soares; Laila Asth; Fabricio A Moreira; Adaliene V M Ferreira; Daniele C Aguiar Journal: Metab Brain Dis Date: 2022-08-30 Impact factor: 3.655
Authors: Daniel I Brierley; Joe R Harman; Natasha Giallourou; Emma Leishman; Anna Emily Roashan; Ben A D Mellows; Heather B Bradshaw; Jonathan R Swann; Ketan Patel; Benjamin J Whalley; Claire M Williams Journal: J Cachexia Sarcopenia Muscle Date: 2019-04-29 Impact factor: 12.910
Authors: Daniel I Brierley; James Samuels; Marnie Duncan; Benjamin J Whalley; Claire M Williams Journal: Psychopharmacology (Berl) Date: 2016-08-09 Impact factor: 4.530